DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹455 Cr | ₹498 Cr | ₹572 Cr | ₹523 Cr | ₹407 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of DIVIS LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹455 Cr |
| Mar2025 | ₹498 Cr |
| Mar2024 | ₹572 Cr |
| Mar2023 | ₹523 Cr |
| Mar2022 | ₹407 Cr |
How is Deferred Tax Assets / Liabilities of DIVIS LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹455 Cr | -8.63 | |
| Mar2025 | ₹498 Cr | -12.94 | |
| Mar2024 | ₹572 Cr | 9.37 | |
| Mar2023 | ₹523 Cr | 28.52 | |
| Mar2022 | ₹407 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹293,908.5 Cr | -1.8% | 20.6% | 70.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | -1.4% | 6.3% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1.9% | 2.4% | 22.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,604.0 Cr | 0.8% | 12.6% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,720.0 Cr | -2.4% | 4.4% | -8.3% | Stock Analytics | |
| MANKIND PHARMA | ₹109,040.0 Cr | -1.9% | 14.5% | 15.5% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -1.8% |
20.6% |
70.4% |
| SENSEX | 0.2% |
9.8% |
-2.9% |
You may also like the below Video Courses